The new chews incorporate Fr3sh technology, which Virbac says cleanses, cools and addresses the digestive causes of bad breath.
According to the company's research, the new chews provide significant daily breath improvement from Day 1 for a full 24 hours1, as well as continued breath improvement over a 2-week period. 90% of owners highlighted an improvement in bad breath following use of the chews1.
Virbac says the product is also scientifically proven to reduce calculus and plaque when given daily.2
Product Manager Claire Lewis said: "With 2 out of 3 pet owners having a least one dog with bad breath3, we are delighted to be able to add new VeggieDent Fr3sh to the Virbac range of oral healthcare products."
For more information, contact your Virbac Territory Manager.
References:
Supplies of the vaccine, which is indicated for the active immunisation for horses against equine arteritis, ran low at the end of last year when Zoetis' existing stock was due to expire without any new stock in place.
For further information, contact your Zoetis Account Manager or the Zoetis Technical Team on customersupportUK@zoetis.com or 0845 300 9084 choosing option 1.
Vets4Pets has unveiled its latest national TV advertising campaign, which airs for the first time during Coronation Street on ITV tonight.
The 30-second commercial was shot at five different locations around the UK and features John Davies-Riand MRCVS Vet Partner at Vets4Pets Leeds and Sarah Scott Vet Nurse Partner at Vets4Pets Kettering.
The commercial is running nationally until 28th March and forms part of a national campaign offering owners of elderly pets a discounted £25 senior pet health check with a vet and a half price bag of senior pet food.
Gill Hammond, Head of Brand Marketing said: "It was really important to us when planning this new campaign that we feature our real partners, they are at the end of the day the core of our business and the faces that our clients see when they visit us. The offer itself, focusing on senior pets is testament to our partners' and their teams' commitment to on-going pet health care."
Lee Ashton, founder of Bugler Smith, the agency behind the new ad said: "Working with Vet4Pets on this project has been a really exciting process. Having got under the skin of the brief, and carried out some initial research within Vets4Pets practices nationwide, the overwhelming and consistent theme from everyone we spoke to, was how they have a real passion for pets and making every difference they can.
"This was key to our message, and we felt it was really important to use their best brand ambassadors (their own vets and veterinary nurses) to introduce the brand to the public, to really demonstrate in a straight forward way what makes them different to other vet practices, and we're really pleased with the outcome."
The RCVS statement, which can be read in full here, highlighted the fact that there is no body of evidence that homeopathy is effective and nor is it based on sound scientific principles. It should therefore be considered as complementary rather than alternative to treatments which are based on sound scientific principles, or for which there is a recognised evidence base.
In fact, the RCVS statement said nothing new. The principle that veterinary surgeons must first prescribe licensed medicines tested for safety and efficacy is enshrined in the Veterinary Medicines Regulations 2013, which say that if there is no veterinary medicine authorised in the United Kingdom for a condition in a particular species the veterinary surgeon responsible for the animal may treat with a veterinary medicine authorised for use in another animal species or for another condition in the same species, or, failing that, either a medicine authorised in the UK for human use, or a veterinary medicine authorised in another member state for use with any animal species in accordance with the Special Import Scheme, or a specially prepared (extemporaneous preparation or special) medicine, or exceptionally a medicine imported from outside the EU.
There are no homeopathic treatments listed by the VMD as 'authorised', just a handful of homeopathic preparations listed as 'registered', something which, as the BAHVS itself points out, means they have not been subjected to the same evaluation as authorised medicines or tested for efficacy.
The BAHVS is fond of using anecdote as evidence of efficacy (see the endorsements at the foot of this page: http://www.bahvs.com/), so one veterinary surgeon has been inviting colleagues to share their experiences of homeopathy causing harm on social media, in order to produce an infographic (pictured above right, click to enlarge) highlighting the very real harm caused when, for example, owners 'vaccinate' against parvo with homeopathic nosodes, only to have a dead litter on their hands.
The draft infographic can be found here.
Do you have a story to add to it? Share it here.
The affected batches are: IsoFlo 250 ml 58006XN, 60003XN, 59005XN, 60006XN, 61001XN, 60016XN, 60017XN, 61018XN, 61015XN, 61016XN, 61017XN, 6062216, 6062225, 6062226, 6062217, 6063738 and Isothesia 250ml 6062335, 6063318.
Manufacturer Zoetis says there were a small number of reports of veterinary surgeons having difficulty in re-sealing the bottles after initial opening as the thread on the screw cap had not been fully formed. This defect does not impact the safety and efficacy of the product for animal use but the concern was related to potential evaporation from opened bottles which did not re-seal fully when closed.
Veterinary surgeons are asked to return any unopened bottles to the wholesaler and dispose of any opened bottles in the usual way. They will be fully reimbursed for the stock.
Zoetis says it has already addressed this packaging issue at the manufacturing site so that new batches of the product are unaffected.
Practices requiring further information on the matter should call Zoetis Technical Services on 0845 300 8034.
In addition to working as a clinician in private practice and for charity, Gudrun has worked in several veterinary-related roles in industry, both in management and as a consultant, as well as being the Chair for the British Veterinary Association’s Good Veterinary Workplace Working Group.
In the new role, Gudrun will work support the implementation of the British Veterinary Association’s Good Veterinary Workplaces Code across the business.
Gudrun said: “Having been heavily involved in the work leading up to the Good Veterinary Workplaces Code during my time at the British Veterinary Association, I can fully relate to the many pressures that veterinary workplaces are currently under.
"Through supportive action and using evidence-based tools, I believe we can make a positive and lasting difference.
“It’s an honour to join Vets4Pets as we begin to implement its many commitments to improving the industry.
"I am excited to work towards a positive future for veterinary workplaces and being able to work with Vets4Pets to build a well-resourced and accessible tool for practices to implement good veterinary workplaces will help our practices to attract and retain the best clinical talent.”
Boehringer Ingelheim Vetmedica Ltd has announced that Metacam is now available for use in pigs as an oral suspension.
Metacam, which contains the non-steroidal anti-inflammatory drug (NSAID) meloxicam, is indicated for the treatment of non-infectious locomotor disorders to reduce inflammation and signs of lameness. It is also licensed for the treatment of mastitis-metritis-agalactia (MMA) syndrome in sows, when used alongside appropriate antibiotic therapy. MMA is a multifactorial condition that can threaten the health of the sow and the lives of her piglets due to a marked decrease or complete cessation in milk production.
Boehringer says treatment with Metacam15 mg/ml oral suspension helps control inflammation and pain associated with the condition, thereby helping to restore productivity and wellbeing in the sow and her offspring.
Metacam 15mg/ml oral suspension for pigs supplements the existing injectable formulation and has been introduced to its increase flexibility and ease of use, and to reduce the potential stress than can be caused when injecting newly-farrowed sows. The palatable suspension can be given mixed with a small quantity of feed or can be administered directly into the mouth.
IVC was formed in 2011, the result of a merger of several independent veterinary hospitals. Under the leadership of David Hillier, and with backing from Summit Partners in 2014, it grew to over 300 practices before being acquired by the Swedish EQT Partners in January 2017.
In August last year the company merged with Evidensia Group, another veterinary corporate group with practices around Europe, bringing the total to more than 850 clinics and hospitals in eight countries.
EQT has reportedly now instructed Jefferies Investment Bank to auction the business in the first week of November.
No word yet on where the auction will take place. If you go, be careful not to scratch your nose at the wrong moment ("1.7 billion from the gentleman at the back. Yes, that's YOU, Sir.").
The five talented winners of the "Vets in your daily life" competition were announced today by DG SANCO, the European Commission's Directorate General for Health and Consumers and the World Organisation for Animal Health (OIE).
DG SANCO launched the worldwide photography competition earlier this year, to coincide with World Vet Year 2011, celebrating the 250th anniversary of the veterinary profession. The five winners are: Somenath Mukhopadhyay (Winner for Asia), Genoveva Kriechbaum (Winner for Middle East), Molly Feltner (Winner for Africa), Ariel Alejandro Corvalán Herrera (Winner for the Americas) and István Konyhás (Winner for Europe). István Konyhás, European winner and leader of the Hungarian Working Group of Cranes said: "The photo I took in Hortobagy's Bird Hospital (a foundation set up for healing injured wild birds) highlights the care put into healing an injured stork. It also reflects the meticulousness of Dr János Déri trying to re-instate the lost parts of the stork's beak with dental treatment. As a volunteer of the foundation I have taken photos of their work for years so I am pleased to be one of the winners and with the prize money, I hope to be able to take even more interesting and striking photos."
István Konyhás' winning photograph highlights the care put into healing an injured stork. © European Commission.Molly Feltner, African winner and Communications Officer for the Mountain Gorilla Veterinary Project (MGVP) commented: "I am delighted to be one of the winners of this photo competition and am particularly proud of what this photos highlights. Working with the MGVP in Rwanda, Uganda and the Democratic Republic of Congo (DRC) we are dedicated to saving the lives of mountain gorillas. This photo beautifully depicts the doctor-patient relationship between MGVP's veterinarians and gorillas."
Molly Feltner's winning photograph depicts the relationship between Mountain Gorilla Veterinary Project veterinarians and gorillas. © European Commission.
Ariel Alejandro Corvalán Herrera's photograph won the Americas category. © European Commission.
The winning image for the Asia Pacific region was taken by Somenath Mukhopadhyay. © European Commission.
Genoveva Kriechbaum was the winner for the Middle East. © European Commission.
This year's Veterinary Week, from Monday 16th to Sunday 22nd May, aims to highlight the contribution of the veterinary profession to society under the slogan "Vets in your daily life." This includes a conference on 'Crisis Management in the Food Chain' (organised by the European Commission) today and tomorrow, during which Commissioner John Dalli will present the prizes to the regional winners of the international photographic competition organised jointly with the World Organisation for Animal Health (OIE). Events to celebrate Vet Week will be taking place across the European Union.
Ludivine, who graduated in 2008, has come over from America to take up the new post, having just completed a three-year residency at the University of Pennsylvania in Philadelphia.
She said: "I’m really enjoying working as part of a great team and working with the various different disciplines here.
"I’m passionate about my ECC speciality and I have a keen interest in respiratory diseases, trauma and acid base disturbances.
"I also like teaching and being updated about the most recent studies in ECC to ensure I can deliver the most up-to-date care possible for our patients."
Ludivine was born in France and originally studied at her home town university in Lyon, progressing to a rotating internship there after graduation.
In 2012, she worked as an emergency veterinary surgeon in several general practices across France and Switzerland, before moving to the United States in 2014 to see how ECC medicine was practiced overseas.
First, she undertook an ECC internship at the University of California, followed by a three-year residency at the University of Pennsylvania.
Away from work, Ludivine enjoys horse riding, running, work-outs and practising her skiing in the French Alps. She also has two dogs Dalhi her Golden Retriever and Baya her German Shepherd.
For more information, visit www.willows.uk.net/en-GB/specialist-services.
'Potential role of veterinary flea products in widespread pesticide contamination of English rivers1, was carried out by Professor Dave Goulson and Rosemary Perkins MRCVS from the University of Sussex and co-authored by Martin (pictured right) and Wayne Civil from the Environment Agency.
For the study, they looked at 3,861 samples taken from 20 rivers around the UK between 2016 and 2018. Fipronil was detected in 98% of the samples and imidacloprid in 66%.
Currently, there are no environmental quality standards for fipronil or the compounds it breaks down into (fipronil sulfone or fipronil sulfide) or for imidacloprid in British surface waters.
The authors therefore used the acute and chronic toxicity limits for fipronil from a report from the Department of Environmental Toxicology at the University of California Davis2, and from Morissey et al (2015)3 for imidacloprid.
They found that the average fipronil concentration across the rivers sampled by the Environment Agency exceeded chronic safety thresholds five-fold. The overall pollution levels in English rivers indicate that fipronil and its toxic breakdown products pose a high risk to aquatic ecosystems.
While, in most rivers, imidacloprid was found to pose a moderate risk, in seven out of the 20 rivers sampled there was a high environmental risk.
The paper, published in Science of the Total Environment, noted that the highest levels of pollution were found immediately downstream of wastewater treatment works, which the authors say supports the hypothesis that significant quantities of pesticide may be passing from treated pets to the environment via household drains.
Professor Dave Goulson said “Fipronil and imidacloprid are both highly toxic to all insects and other aquatic invertebrates. Studies have shown both pesticides to be associated with declines in the abundance of aquatic invertebrate communities. The finding that our rivers are routinely and chronically contaminated with both of these chemicals and mixtures of their toxic breakdown products is deeply troubling.”
Bathing of pets treated with spot-on fipronil flea products has been confirmed as a potentially important route to waterways for fipronil via sewers. The washing of hands, pet bedding or other surfaces that have come into contact with treated pets are potential additional pathways for entry to sewers.
Rosemary said: “We’ve identified a number of steps that can be taken to minimise or avoid environmental harm from pet flea and/or tick treatments. These range from introducing stricter prescription-only regulations, to considering a more judicious and risk-based approach to the control of parasites in pets, for example by moving away from blanket year-round prophylactic use."
Martin said: "The profession urgently needs to adopt ‘responsible use of parasiticides’ similar to the way it is adopting responsible use of antimicrobials. The VMD needs to strengthen the environmental assessment of pet pesticide products in the authorisation process, and they are currently considering this issue. The VMD should also collate and publish annual sales figures for these pesticides as they do for antimicrobials."
He added: "My veterinary hospital has never had a ‘pet health plan’ to provide year round flea products, because we believe that year-round, intensive treatment for almost all dogs and cats does not constitute responsible use of such powerful pesticides."
References
Morrissey, C.A., et al., 2015. Neonicotinoid contamination of global surface waters and associated risk to aquatic invertebrates: a review. Environ. Int. 74, 291–303. https://doi.org/10.1016/j.envint.2014.10.024.
The Sutton Bonington Campus, home of the University of Nottingham's School of Veterinary Medicine and Science, has raised £610 for Sport Relief with its annual Science Cake Competition.
There were thirty entries to the competition, in categories which included Animals & Agriculture, Food & Nutrition, Infection, 'Nerdy' Science, Plants, Crops & Environment, and Veterinary Medicine.
A special category this year was 'Cakes for Animals', which Emily Blight, an undergraduate vet student, organised for a panel of dogs to judge on tastiness.
The winner of the public vote was 'What came first, the chicken or the cake?' (pictured right), whilst the overall winner was Alex Burgess with ‘Dave’s Allotment’.
One of the judges, Dr Mike Jones said: "Choosing the winner was extremely hard. Every cake had its own specific merits be it the execution of the design, through to the novelty of ingredients and ideas or how they fitted into the categories." He added that he "was almost put off jelly beans for life - they will be forever associated with sheep back sides."
The cakes are all on display here.
Speaking at Improve International's OV Conference last week, Dr Wright cited increased pet travel and importation as key risk factors, including the growing number of rescued dogs arriving in the UK from countries in Europe and further afield.
Dr Wright highlighted the Rhipicephalus tick (Rhipicephalus sanguineus) as being a particular cause for concern, as it can transmit Ehrlichia canis, Anaplasma platys, Rickettsias, Babesia vogeli and Hepatozoon.
Dr Wright said that Ehrlichia canis and Anaplasma platys are among the most common tick-borne diseases in imported dogs, particularly those arriving from Eastern and Southern Europe. There were also three cases of Hepatozoon canis in 2018, caused by dogs ingesting Rhipicephalus ticks while grooming.
According to figures from a Bristol University Pet Travel survey, 54.5% of dog travel on the Pet Travel Scheme from the UK is to France with Southern European countries also popular destinations. These are all countries in which Rhipicephalus is present and on the increase. Dr Wright said that the ticks are moving north into Austria, Switzerland, Central France, Romania and Bulgaria.
During the last few months, he has also been alerted to ticks found on dogs coming in from North America, Latin America and Africa. These bring with them the risk of new diseases, including a variety of zoonotic rickettssial pathogens, such as Rickettsia Rickettsii, which causes Rocky Mountain Spotty Fever.
To address this issue Dr Wright urged vets to redouble their efforts on tick prevention. In particular, he recommended tick prevention pre/during and post travel, using products that offer rapid kill and repellency in order to reduce transmission, repellents being especially important in Leishmania infantum and Rhipicephalus-endemic countries.
Dr Wright recommended drilling clients and staff on tick removal and reminding them that finding a tick on a pet is not a failure as no product is 100% reliable and it is easy to miss them in long-haired dogs. He also suggested asking clients to take photos of any ticks they find on their pet while abroad so that their vet will know on their return what pathogens they may have been exposed to. If necessary, the Public Health England Tick Surveillance Scheme can help with identification.
Dr Wright suggested that legislation to enforce tick treatment on entry was a poor strategy used in isolation as pets would still be exposed while abroad and no product is completely reliable. It would be useful however, to raise awareness and show that we are taking the issue of tick-borne disease seriously.
He said: "We’re seeing a significant increase in pet travel and import a wider range of countries from which dogs are being imported and this is significantly increasing our exposure to exotic ticks.
"What’s news about this is that while you could argue that diseases such as Lyme Disease are ‘lifestyle’ diseases because people and dogs are exposed to our native ticks while out enjoying the countryside, the Rhipicephalus tick comes to your home, exposing you to a wealth of rickettsial diseases for the first time. We are already seeing instances of this in France, Germany and Scandinavia and, as pet travel continues to grow, the risk here will only increase. It’s equally possible that a dog with a native tick could travel aboard and return hosting a new pathogen.
"The only way to manage this risk is to provide consistent advice to the public and to support increased disease surveillance. Vigilance is key – assume that any travelling dog may have ticks and do not assume that because it is tick-treated, it’s a case of ‘job done.’"
He said: "Put the onus on clients - gently. Remind them to seek advice, to check for ticks and to keep tick treatments up to date. Also remind them to visit the practice with their dog as soon as possible on their return. If you do find exotic ticks, please send them to the Tick Surveillance Scheme for identification."
He added: "If you know an owner who is planning to adopt a dog from abroad, explain the risks to them and encourage them to adopt from the UK. If they are determined to go ahead, work with them to ensure that you reduce the risk of exotic ticks arriving with their new family members. The risk to human and animal health from an infestation should not be underestimated."
Batches 060K80412C1A-UK1-2 and 060K80412A1C-UK1-2 (expiry 12/06/2019) have been recalled due to incorrect storage requirements during shipment.
For further information, contact Jerome Martineau at: jerome.martineau@filavie.com, or telephone: +33 2 41 754616
Evidence given to the Women and Equalities parliamentary committee by BUPA last year suggested that 900,000 women may have left the UK workforce in recent years as a result of menopausal symptoms.
With the veterinary profession increasingly female in composition it is hoped that the hub will support more women to stay in the profession and therefore retain their vital skills in the workforce.
Statistics from the Voice of the Veterinary Profession Spring 2023 survey showed that only 14% of vets are aware of a menopause policy at their workplace, while 46% say there is no policy and 39% are unsure.
The survey also revealed that only 59% of vets would feel confident supporting a colleague experiencing menopause.
The new menopause hub provides veterinary specific menopause content to support everyone working in practice including colleagues, managers and partners of people experiencing menopause.
BVA recently signed the Menopause Workplace Pledge – committing to take positive action to make sure everyone experiencing menopause is supported - and is now urging other veterinary employers to do the same.
British Veterinary Association Junior Vice President Anna Judson, said: “We know that menopause is of growing importance to our profession, with female vets now making up more than half the workforce, and we know that issues with managing menopause symptoms prompt a significant number of women to move away from clinical work.
“As part of our Good Veterinary Workplaces campaign we’re committed to supporting all veterinary staff affected by menopause, allowing them to remain in post, and to providing relevant resources to improve employer engagement in this area.
"We urge all veterinary workplaces to sign the pledge and consider what more they could be doing to support their staff in managing menopause symptoms in the workplace.”
BVA members experiencing menopause are also eligible for 3 months free access to the Stella app, which includes a personalised plan to manage your specific symptoms, real-life coach support, menopause resources, progress tracking, and a supportive community.
Content on the Stella app is created in collaboration with a range of clinicians and healthcare professionals and goes through a rigorous fact-checking and review process.
https://www.bva.co.uk/menopause-hub
'Hany’s Heartbreak' was a gorily realistic representation of a dog’s heart infected with Dirofilaria Immitis, baked by vet students Anna Burrows, Caitlin Glover, Chloe Tredinnick and Liberty Daly.
It pulled in votes from all over the world including Australia and the US, Saudi Arabia, Germany, Italy and the Caribbean.
The winning bakers said: "We chose to bake this cake as we wanted to make something that we could make look as realistic as possible and as gruesome.
"Our parasitology lecturer, Hany, inspired us to use the D. Immitis parasite as our theme to promote the message of how detrimental and possibly fatal some animal parasites can be! We had a great time baking it and enjoyed the looks of disgust that people who saw it gave. We promise it tastes better than it looks! Our key message to everyone is to PLEASE WORM YOUR PETS!"
The categories for baking inspiration this year were Transport to Campus, Scrumptious Science, Blue Planet and a Showstopper section. Sir David Attenborough and Pixar characters Nemo and Dory were among the other stars of the show, with colourful cakes on an environmental theme also winning prizes.
One of this year’s judges was Dr Wendela Wapenaar, Associate Professor at the Nottingham Vet School. Wendela said: “It’s been another great year for the Sutton Bonington Bakeoff. It was impressive to see how some bakers took on the challenging topics for this year; winning cakes were covering topics such as global warming, environmental pollution in addition to the more gory aspects of veterinary medicine."
The group, which was founded over 70 years ago, now employs over 300 people, more than 85% of whom are female. Many occupy senior and leadership positions: 6 out of 13 of the partners are female.
Wendy Furness, a Partner at Scarsdale Vets said: "Scarsdale Vets represents a microcosm of how women’s roles could be in a world of gender equality in business.
"Here we have people in every role that you can imagine, from client-facing roles such as client care advisors, vets and nurses, to people that make the business function happen, such as marketing and finance managers.
"We want women to be inspired to be who they want to be. There are many roles that some people still first think of as male dominated, such as surgeons and farm or equine vets.
"However, we at Scarsdale Vets are challenging assumptions like these and looking for opportunities to make all roles visible to women.”
Wendy added: "Having women in leadership and senior roles is essential if women at the start of their careers are to succeed. We can be there to inspire the next generation to strive for these positions, if that is what they want, and see that it is made possible. We can also stand up and be counted if and when bias based on gender is observed."
To mark International Women’s Day, Scarsdale Vets is filling its social media channels with positive images of women, working in the diverse roles within the practice, challenging stereotypes about the veterinary roles available to women, influencing others positively, and celebrating the successes of the women in their team.
https://www.facebook.com/ScarsdaleVets/posts/2097073290308906
Photo: Rose Jackson MRCVS, a farm animal vet at Scarsdale Markeaton. Courtesy Scarsdale Vets.
Doxycare is a doxycycline indicated for the treatment of bacterial respiratory tract infections in cats and dogs due to organisms sensitive to doxycycline, and for the treatment of tick-borne Ehrlichia canis infection in dogs. Doxycare is presented in two strengths: 40mg and 200 mg. Both are licensed for use in cats and dogs. The meat-flavoured tablets are scored for quarter splitting to support more accurate dosing.
Metrocare is a metronidazole indicated for the treatment of gastrointestinal tract infections caused by Giardia spp. and Clostridia spp. and the treatment of infections of the urogenital tract, oral cavity, throat and skin caused by obligate anaerobic bacteria. Metrocare is available in two strengths: 250mg and 500 mg. Both are licensed for use in cats and dogs. The meat-flavoured tablets are scored for quarter splitting.
Cephacare, Animalcare’s first-generation cephalosporin, is now also available in a 1000 mg strength meat-flavoured tablet. Cephacare is licensed to treat skin infections, urinary tract infections, respiratory tract infections, digestive tract infections and infections of the oral cavity. The existing 50 mg strength tablet is licensed for use in cats and dogs. The new 1000 mg size tablets are scored to be halved and licensed for use in larger dogs.
James Beaumont, Product Manager, said: "We aim to offer our customers flexible and convenient solutions for the products they need to use every day in practice, while supporting more accurate and responsible dosing. The additions of Doxycare and Metrocare to our range, together with the new 1000 mg Cephacare strength tablet, mean that we are now able to offer a broader range of antibiotics for use in both cats and dogs."
GRAM (Guidance for the Rational use of AntiMicrobials) is a 500-page guide written by a panel of 10 independent European experts from the fields of microbiology, pharmacology and dermatology, all of whom are specialists in internal medicine, surgery and epidemiology. Based on rational use with compliance at the forefront, GRAM provides tools for improved diagnosis and positive treatment outcomes.
The guide consists of 37 disease fact sheets, 29 practical recommendations and six reference synopses. It features a range of topics including:
Andy Forsyth, senior technical veterinary advisor at Ceva said: "Antimicrobial resistance continues to be a concern in both human and animal health. GRAM will help educate veterinary professionals on how they can play their part in creating sustainable antibiotic use."
To request a copy of GRAM or for further information on sustainable antibiotic use, contact your local Ceva Animal Health territory manager.
Veterinary medicines are defined in the Veterinary Medicines Regulations as:
"any substance or combination of substances that may be used in, or administered to, animals with a view either to restoring, correcting or modifying physiological functions by exerting a pharmacological, immunological or metabolic action, or to making a medical diagnosis."
On this basis, the VMD says CBD products for use in animals require a marketing authorisation before they can be sold or supplied in the UK.
There are currently no CBD based products that have been granted a UK veterinary marketing authorisation which means that under the cascade, veterinary surgeons must prescribe a legally obtained human CBD product.
Photo: Shutterstock / Lifestyle discover
Nutricat, a supermarket cat food launched this year, has released the results of a survey which, it says, shows that modern day lifestyles are resulting in British cat owners anthropomorphising their cats.
The survey found that 54% of cat owners believe their cat shares similar emotions to them, 40% sign greetings cards from their cat, and 1/3 say their cat is a better listener than their partner.
Anthropomorphism is nothing new, and since the press release came from a supermarket brand, it would ordinarily have been destined for the 'Deleted Items' folder.
However, one thing caught my eye. In the press release, Nutricat was described as: a new brand of veterinarian approved advanced feline nutrition'.
But it's not just how Nutricat is described in the press release. The title of the Nutricat website is: 'Veterinarian approved cat food', and the words 'veterinarian approved' appear no less than 3 times on the home page. It doesn't stop there. Tesco seems to have got the message too.
So how many veterinary surgeons are required to endorse something in order to claim, reasonably, that it is 'veterinarian approved'. A couple of RCVS Specialists in Feline Medicine? 10 general practitioners? 20? 50? 100?
VetSurgeon.org rang the PR agency for Nutricat and asked the question.
The answer is one.
What do you think? Take part in our poll, here: http://www.vetsurgeon.org/forums/t/9928.aspx
The journal publishes original peer-reviewed papers of international or global significance that improve the veterinary care and welfare of domestic cats.
Until this year, access to JFMS for most veterinary practitioners was dependent on membership to the International Society of Feline Medicine (ISFM) or the American Association of Feline Practitioners (AAFP), or a separate paid subscription.
Now that the journal is open access, there are no restrictions on who can access the journal and all articles past and present are free to view.
The journal's editors say that making it open access greatly improves their ability to improve the health and welfare of cats by providing high-quality peer-reviewed information.
The AAFP and ISFM say they have already seen the positive impact this has had, with low- and middle-income countries now accounting for a quarter of the 20 most common geographic locations for visitors to the JFMS website.
Head of ISFM Nathalie Dowgray said: "Transitioning JFMS to an open access journal helps ISFM fulfil our parent charity’s (International Cat Care) mission of creating a cat friendly world through ensuring the latest knowledge in feline medicine and welfare is available to the global veterinary community."
For those interested in submitting to JFMS, authors can get a 50% discount on the article processing charge until 4 July 2023; after this date, a 22% discount will be in place for authors who are a member of ISFM or the AAFP.
Click here for more information about submitting an article to JFMS: https://journals.sagepub.com/author-instructions/JFM
https://journals.sagepub.com/home/jfm
Pedigree has announced that it has raised over £160,000 to help the thousands of dogs abandoned every year in the UK, through its charitable initiative, The Pedigree Adoption Drive 2011.
Pedigree says its fundraising comes at a crucial time, as rescue centres' facilities across the country are severely suffering under the strain of the highest level of dog abandonment in over a decade.
The Pedigree Adoption Drive, which launched in mid-October, aims to raise awareness of the ever-increasing issues of dog abandonment and funds for the hundreds of rescue centres across the country that work tirelessly to find these dogs new loving homes.
Now in its fourth year, the campaign called upon dog lovers everywhere to show their support, by taking part in the world's first virtual dog walk around the web. In addition, consumers got involved in a host of other activities - donating via text message and online, to help the Drive reach this year's grant total.
The funds raised this year will be distributed through grants to 90 rescue homes across the country - including three special grants of £15,000 given to Bath Cats and Dogs Home, £20,000 given to North Clwyd Animal Rescue and £25,000 given Birmingham Dogs Home. Every grant will be put towards projects aimed at making tomorrow better than today for dogs - including the refurbishment of dilapidated kennel blocks, desperately needed veterinary facilities and the supply of essential surgical equipment.
TV presenter and vet Steve Leonard, who is the ambassador of this year's campaign, said: "The money raised from this year's Pedigree Adoption Drive is a great example of how we can achieve so much together to help take steps towards tackling the issue of dog abandonment. The grants awarded to rescue centres this year will make a big difference in helping to find many rescue dogs, the loving homes they deserve."
Katie Wragg, Pedigree Adoption Drive Brand Manager said: "In the last four year's we've raised over £1million for rescue centres supporting the country's abandoned dogs and despite the tough economic climate, the amazing public reaction has enabled us to really make a difference to the lives of abandoned dogs across the UK and help give them a bright future."
For more information on the campaign log on to: http://www.pedigreeadoptiondrive.com/
Virbac has been granted a Limited Marketing Authorisation in the UK for its Gudair vaccine, indicated for the active immunisation of sheep and goats against Mycobacterium avium subspecies paratuberculosis (MAP).
MAP is the causal organism for Johne's Disease, a chronic infection of the intestinal system for which there is no cure.
According to Virbac, Johne's Disease enters most flocks following the introduction of infected stock, often breeding rams, bought at markets without checks on disease provenance. It is then spread by the faeces of often apparently healthy animals but which can contain huge numbers of MAP. The main clinical sign is a thin ewe resulting in poor productivity followed by inevitable death. It can be passed between sheep and cattle.
Ovine Johne's Disease (OJD) in sheep is widespread in Australia where annual death rates of up to 17% have been seen in infected flocks. Virbac says that trials conducted there have demonstrated that vaccination with Gudair can reduce the number of deaths due to OJD by 90% and reduce the numbers of OJD-causing organisms excreted in sheep faeces by 90%.
Ken Sibley MRCVS, Technical Advisor at Virbac says that the number of infected flocks in the UK is unknown and the disease often remains undiagnosed: "Johne's Disease can be a significant cause of loss in infected sheep flocks because of reduced productivity and high culling rates. Vaccination provides the only possible assurance when sourcing sheep from potentially infected flocks and will help to reduce losses from the disease should a farmer inadvertently introduce sheep into an infected flock.
"Lambs identified as replacements should generally be vaccinated between 4 and 16 weeks of age, subcutaneously behind the ear. Sheep over 16 weeks of age can also be vaccinated as this will reduce shedding of organisms in infected animals while bought-in replacements can be vaccinated on arrival at the farm. Sheep require only one vaccination for their lifetime.
"Following its success in Australia, we are delighted to be able to offer Gudair to veterinary surgeons in the UK."
For further information, contact your Virbac territory manager or call: 01359 243243
Cosacthen contains 0.25 mg/ml of tetracosactide which had only previously been available as human-registered or compounded veterinary ‘special’ preparations meaning availability and cost could be unpredictable.
Tetracosactide is used in the ACTH stimulation test to assess the adrenocortical function of patients with endocrine diseases, such as Cushing’s and Addison’s.
Dechra Brand Manager Claire Morgan said: “As experts in endocrinology, we recognise that the testing involved in adrenal conditions can be a costly process for pet owners, which can mean that some cases don’t progress to treatment or have their treatment optimised.
"The launch of Cosacthen gives veterinary surgeons the reassurance associated with a veterinary licensed medicine. As these cases can appear on an irregular basis, Cosacthen is ideal to keep in the practice ready for when a case is presented making it a cost-effective solution that can help offset the cost for owners of long-term treatment of adrenal conditions."
Cosacthen is available in 1 ml single-use vials.
For more information visit www.dechra.co.uk/cosacthen.